Browse by category

A research team at the Hartford HealthCare Digestive Health Institute (DHI) will launch a new study, funded by a US$2.9-million federal...

People who are scheduled for certain medical procedures should stop taking glucagon-like peptide-1 receptor agonists (GLP-1RAs)...

Welcome to our weekly round-up of the latest bariatric and obesity-related papers published in the medical literature. As ever, we have...

Bariatric surgeries can correct abnormal R wave progression and resolve QT dispersion in morbidly obese patients, according to...

Three independent, preliminary research studies have found that new type 2 diabetes and weight-loss medications are often not prescribed...

There is no association between prescription glucagon-like peptide-1 (GLP-1) agonist medications and increased risk of aspiration or...

Welcome to our weekly round-up of the latest bariatric and obesity-related papers published in the medical literature. As ever, we have...

Entera Bio has revealed positive pharmacokinetic results from its collaborative research combining a proprietary long acting GLP-2...

Australian researchers have discovered that a bedtime nasal spray has the potential to reduce the severity of obstructive sleep apnoea...

Middle-age obesity is caused by age-related changes in the shape of neurons in the hypothalamus, a region of the brain that controls...